Craig J McClain Selected Research

Fatty Liver

12/2021	Associations Between Residential Exposure to Volatile Organic Compounds and Liver Injury Markers.
1/2021	Beneficial effects of an endogenous enrichment in n3-PUFAs on Wnt signaling are associated with attenuation of alcohol-mediated liver disease in mice.
1/2020	Corrigendum to 'Fibroblast growth factor 21 is required for the therapeutic effects of Lactobacillus rhamnosus GG against fructose-induced fatty liver in mice' Mol Metabol 29 (November 2019) 145-157.
11/2019	Fibroblast growth factor 21 is required for the therapeutic effects of Lactobacillus rhamnosus GG against fructose-induced fatty liver in mice.
1/2019	Chalcone Derivative L6H21 Reduces EtOH + LPS-Induced Liver Injury Through Inhibition of NLRP3 Inflammasome Activation.
10/2018	Intestinal HIF-1α deletion exacerbates alcoholic liver disease by inducing intestinal dysbiosis and barrier dysfunction.
1/2018	Liver Disease in a Residential Cohort With Elevated Polychlorinated Biphenyl Exposures.
1/2017	Activation of autophagy attenuates EtOH-LPS-induced hepatic steatosis and injury through MD2 associated TLR4 signaling.
11/2016	Role of dietary fatty acids in liver injury caused by vinyl chloride metabolites in mice.
4/2016	Saturated and Unsaturated Dietary Fats Differentially Modulate Ethanol-Induced Changes in Gut Microbiome and Metabolome in a Mouse Model of Alcoholic Liver Disease.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Craig J McClain Research Topics

Disease

43	Inflammation (Inflammations) 10/2022 - 06/2003
36	Non-alcoholic Fatty Liver Disease 01/2021 - 08/2003
33	Alcoholic Liver Diseases (Alcoholic Liver Disease) 12/2020 - 06/2002
26	Fatty Liver 12/2021 - 06/2003
18	Liver Diseases (Liver Disease) 01/2022 - 03/2004
15	Alcoholic Hepatitis 06/2021 - 07/2002
15	Obesity 01/2020 - 01/2003
13	Alcoholism (Alcohol Abuse) 12/2020 - 05/2004
13	Fibrosis (Cirrhosis) 01/2020 - 07/2002
10	Necrosis 01/2021 - 01/2003
10	Endotoxemia 01/2017 - 07/2002
9	Insulin Resistance 11/2021 - 02/2010
9	Body Weight (Weight, Body) 01/2021 - 06/2002
8	Hepatitis 10/2022 - 05/2008
7	Infections 01/2022 - 06/2002
7	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2006 - 10/2003
6	End Stage Liver Disease 10/2022 - 12/2008
6	Alcoholic Fatty Liver 01/2018 - 08/2003
5	Metabolic Syndrome (Dysmetabolic Syndrome X) 11/2018 - 02/2012
4	Dysbiosis 01/2022 - 12/2019
4	Muscle Cramp (Cramp) 11/2021 - 05/2013
4	Virus Diseases (Viral Diseases) 08/2020 - 07/2016
4	Hypoxia (Hypoxemia) 01/2020 - 09/2003
4	Neoplasms (Cancer) 01/2020 - 08/2013
4	Mitochondrial Diseases (Mitochondrial Disease) 01/2018 - 08/2004
4	Iron Overload 06/2015 - 10/2011
4	Wounds and Injuries (Trauma) 10/2009 - 05/2004
3	Malnutrition (Nutritional Deficiencies) 01/2018 - 02/2011
3	Burns 04/2017 - 06/2005
3	Hepatitis C 01/2017 - 02/2004
3	Hemorrhagic Shock 03/2016 - 11/2012
3	Alcoholic Liver Cirrhosis (Alcoholic Cirrhosis) 01/2005 - 08/2003
2	Liver Neoplasms (Liver Cancer) 12/2021 - 07/2007
2	Hemangiosarcoma (Angiosarcoma) 05/2021 - 02/2010
2	Cytokine Release Syndrome 08/2020 - 01/2020

Drug/Important Bio-Agent (IBA)

27	CytokinesIBA 01/2021 - 06/2002
18	Ethanol (Ethyl Alcohol)IBA 01/2022 - 06/2003
17	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2017 - 07/2002
16	ZincIBA 10/2022 - 06/2003
16	Proteins (Proteins, Gene)FDA Link 11/2021 - 01/2003
16	FructoseIBA 01/2021 - 07/2009
15	Alanine Transaminase (SGPT)IBA 06/2021 - 06/2003
15	Biomarkers (Surrogate Marker)IBA 05/2021 - 10/2011
10	CopperIBA 01/2021 - 05/2008
9	LipidsIBA 06/2021 - 09/2007
8	EndotoxinsIBA 01/2019 - 01/2003
7	Pentoxifylline (Trental)FDA LinkGeneric 10/2022 - 08/2003
7	Fatty Acids (Saturated Fatty Acids)IBA 05/2021 - 04/2014
7	S-Adenosylmethionine (Ademetionine)IBA 05/2011 - 07/2002
6	Keratin-18 (Keratin 18)IBA 01/2021 - 10/2008
6	Triglycerides (Triacylglycerol)IBA 01/2021 - 01/2003
6	Dietary Fats (Dietary Fat)IBA 01/2020 - 05/2012
6	AntioxidantsIBA 07/2012 - 03/2004
5	AdiponectinIBA 11/2021 - 12/2005
5	Linoleic Acid (Linoleate)IBA 06/2021 - 05/2013
5	LipopolysaccharidesIBA 02/2021 - 01/2003
5	EnzymesIBA 11/2020 - 01/2003
5	Betaine (C.B.B.)FDA Link 01/2018 - 03/2004
4	Adrenal Cortex Hormones (Corticosteroids)IBA 10/2022 - 08/2003
4	fibroblast growth factor 21IBA 11/2021 - 08/2015
4	Vinyl Chloride (Chloroethylene)IBA 05/2021 - 02/2010
4	Bile Acids and Salts (Bile Acids)IBA 05/2021 - 12/2019
4	Pharmaceutical PreparationsIBA 08/2020 - 05/2008
4	Polychlorinated Biphenyls (PCBs)IBA 01/2018 - 12/2010
4	CarbohydratesIBA 01/2018 - 03/2008
4	ChemokinesIBA 03/2016 - 11/2003
4	Interleukin-6 (Interleukin 6)IBA 01/2015 - 01/2003
4	Interleukin-8 (Interleukin 8)IBA 08/2011 - 11/2003
3	Methylprednisolone FDA LinkGeneric 10/2022 - 01/2017
3	Antimicrobial PeptidesIBA 11/2021 - 01/2019
3	CathelicidinsIBA 11/2021 - 01/2019
3	OxylipinsIBA 06/2021 - 01/2018
3	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2021 - 10/2011
3	MicroRNAs (MicroRNA)IBA 01/2021 - 01/2016
3	InflammasomesIBA 12/2020 - 01/2018
3	Environmental Pollutants (Pollutants, Environmental)IBA 02/2020 - 12/2010
3	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2019 - 05/2005
3	LeptinIBA 01/2018 - 10/2003
3	BilirubinIBA 01/2017 - 12/2008
3	Glucose (Dextrose)FDA LinkGeneric 01/2014 - 06/2008
3	Methionine (L-Methionine)FDA Link 05/2011 - 03/2004
3	S-AdenosylhomocysteineIBA 05/2011 - 10/2004
3	Transforming Growth Factor beta (TGF-beta)IBA 09/2004 - 02/2004
2	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 10/2022 - 01/2020
2	milk-derived factorIBA 10/2022 - 01/2017
2	Butyrates (Butyrate)IBA 01/2022 - 01/2020
2	Neutral CeramidaseIBA 01/2022 - 01/2021
2	Amino Acids FDA Link 05/2021 - 02/2015
2	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 02/2021 - 01/2019
2	InterleukinsIBA 01/2021 - 12/2020
2	Peptides (Polypeptides)IBA 12/2020 - 03/2016
2	Uric Acid (Urate)IBA 12/2020 - 11/2020
2	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 11/2020 - 03/2012
2	Thiamine (Aneurin)FDA Link 08/2020 - 01/2020
2	Interleukin-17 (Interleukin 17)IBA 08/2020 - 01/2020

Therapy/Procedure

29	Therapeutics 10/2022 - 01/2003
4	Liver Transplantation 01/2022 - 03/2004
4	Resuscitation 03/2016 - 06/2005
3	Ligation 01/2020 - 05/2008
3	Complementary Therapies (Alternative Medicine) 07/2007 - 08/2003